TEAM

SPR Therapeutics is led by an experienced management team with a long history of success in researching, developing and commercializing neurostimulation products. Our clinical and scientific advisors are also renowned worldwide as leaders in interventional pain management, rehabilitation medicine, orthopedics and biomedical engineering.



Executive Management


MARIA E. BENNETT
MARIA E. BENNETT
President, CEO and Founder

Maria (Walker) Bennett has led SPR Therapeutics since its inception. Prior to the formation of SPR, Ms. Bennett served as the VP of Clinical Affairs at NDI Medical, LLC a medical device development company where she played a vital role in the development of a neurostimulation system addressing urinary incontinence, which was acquired by Medtronic in 2008 company for $42 million. Prior to joining NDI, Ms. Bennett was a Clinical Project Manager at Boston Scientific, leading a team that conducted a large, multi-center clinical trial demonstrating safety and efficacy of an innovative angioplasty balloon, and achieving a 510(k) clearance for this product. Prior to this, she was the Manager of Clinical Studies and Director of Research and Development at NeuroControl Corp., where she co-developed a neurostimulation treatment for post-stroke shoulder pain. In 2009, she was selected by Springboard Enterprises as one of thirty female entrepreneurs from over 100 applicants to present at its LifeScience Venture Forums. She is the inventor of the SPRINT™ System, having patents issued and pending. Ms. Bennett holds a master’s degree in biomedical engineering from Case Western Reserve University and a bachelor’s degree from Miami University (OH) in engineering management.




JOSEPH BOGGS Ph.D.
Vice President, Research
and Development

Dr. Boggs has experience developing an R&D pipeline of patented technologies with competitive advantages to deliver safe and effective neuromodulation therapies to fill unmet clinical needs. Prior to joining SPR, he served as Director of Research for NDI Medical, LLC, where he led the research and development of minimally invasive peripheral nerve stimulation (PNS) systems to treat neurological disorders. While at NDI, he advanced the development of the intellectual property portfolio and the next generation technology to treat multiple urological indications with NDI’s Medstim system, which was acquired by Medtronic in 2008. Prior to joining NDI, Dr. Boggs conducted research at Duke University and Case Western Reserve University, focused on developing innovative and minimally invasive PNS technology.

Dr. Boggs has over 12 years of experience designing, directing, and executing preclinical and clinical trials of medical devices that deliver therapeutic electrical stimulation. He has over 8 years of experience serving as a principal investigator for federally awarded research grants from the National Institutes of Health and the Department of Defense. He has several peer-reviewed publications in addition to many patents and patent applications issued and pending.

He has received several awards for his work in neurostimulation. He serves on the Secretary of Veterans Affairs’ Advisory Committee on Prosthetics and Special Disabilities Programs, which provides guidance on the research and development of rehabilitation technology, services, and other programs that serve veterans with serious incapacities. Dr. Boggs also serves on NIH study sections, VA grant review panels, DoD peer review panels, and the editorial board for a peer-reviewed journal.

Dr. Boggs received a B.S. degree in Electrical Engineering from the University of Virginia and later obtained his M.S. and Ph.D. degrees in Biomedical Engineering from Case Western Reserve University.




MARK STULTZ
Senior Vice President,
Market Development

Mark has been actively involved in health care and medical device market development for over 25 years having held senior positions at both large and emerging medical device companies spanning multiple disease states and technologies. Much of Mark’s past work has involved global market development for implantable product lines, with nearly 20 years spent specifically in neuromodulation at companies or with clients such as Medtronic and Nevro (pain management), Advanced Bionics (deep brain stimulation, cochlear implants), and EnteroMedics (high frequency nerve blocking to treat obesity). Prior to serving at EnteroMedics Mark led the market development efforts in women’s health at Gyrus Medical (RF-powered gynecologic laparoscopic instruments) and at American Medical Systems (female/fecal incontinence and prolapse repair systems). Prior to completing graduate studies in human factors engineering and ergonomics and his subsequent entry into the medical device arena Mark spent several years in clinical practice as a physical therapist specializing in orthopedics and sports medicine.



DAVID YOUNGBERG
DAVID YOUNGBERG
Vice President, Sales

Dave Youngberg joins the SPR Therapeutics team with over 25 years of experience in the medical device and pharmaceutical industry, most recently having served in sales leadership at Nevro . Prior to Nevro, Dave served as Vice President of Sales for CNS Therapeutics where he lead the sales team in the launch of Gablofen. Mr. Youngberg continued with his position as head of the Intrathecal Sales Team after CNS was acquire by Coviden/Mallinckrodt in the fall of 2012. Prior to CNS, He was the Director of Sales for Restore Medical, which went public in 2006 and was later acquired by Medtronic. Mr. Youngberg has also held various sale leadership positions at Medtronic, Horizon Medical and Ethicon. He has a B.A. in Economics from the University of MN and served in the U.S. Navy.



Scientific and Clinical Advisors

JOHN CHAE MD
JOHN CHAE MD
Chief Medical Advisor

Dr. Chae serves as SPR Therapeutics’ Chief Medical Advisor and is presently Professor and Chair of Physical Medicine and Rehabilitation (PM&R) at Case Western Reserve University (CWRU) and Director of the MetroHealth Rehabilitation Institute of the MetroHealth System. He is also Professor of Biomedical Engineering at CWRU. He received his Bachelor of Science (’84) and Masters (’86) in Engineering from Duke University and Dartmouth College, respectively. He received his MD (’90) from New Jersey Medical School and clinical training in PM&R (’94) from New Jersey Medical School and Kessler Institute for Rehabilitation. He completed the NIH sponsored Rehabilitation Medicine Scientist Training Program Fellowship (’98) at CWRU.

His research is funded by the NIH and focuses on the application of electrical stimulation for neuroprostheses, neural plasticity and shoulder dysfunction in hemiplegia. He has received numerous awards, including the 2007 Braddom Research Award from the Association of Academic Physiatrists, which “recognizes an individual who over the previous decade has…had the most significant impact on the science and practice of rehabilitation medicine.”

Dr. Chae is a member of the Institute of Medicine of the National Academies and the College of Fellows of the American Institute of Medical and Biological Engineering. He serves on the Board of Scientific Counselors for the NIH Clinical Center, the Board of Trustees of the Association of Academic Physiatrists, and the Editorial Board of the American Journal of Physical Medicine and Rehabilitation.



WARREN GRILL PH.D
WARREN GRILL PH.D
Chief Scientific Advisor

Warren M. Grill serves as SPR Therapeutics’ Chief Scientific Advisor and is presently the Addy Professor of Biomedical Engineering at Duke University (Durham, NC) with secondary appointments in Neurobiology and Surgery. Dr. Grill received a bachelor’s degree in biomedical engineering with honors from Boston University and a Ph. D. in biomedical engineering from Case Western Reserve University, Cleveland, OH. His research interests are in neural engineering and neural prostheses including design and testing of electrodes and stimulation techniques, the electrical properties of tissues and cells, and computational neuroscience with applications in restoration of bladder function, treatment of movement disorders with deep brain stimulation, and multi-joint limb movement. He has authored 90 peer-reviewed publications, and is an inventor on 9 issued and 5 pending patents. In 2007 he was elected as a Fellow of the American Institute of Medical and Biological Engineering, in 2008 received the Capers & Marion McDonald Award for Excellence in Teaching and Research at Duke University, and in 2009 was inducted into the Bass Society of Fellows at Duke for excellence in teaching and research.

Dr. Grill serves as a Consultant to the Neurological Devices Panel of the Medical Devices Advisory Committee, Center for Devices and Radiological Health, U.S. Food and Drug Administration, as an Associate Editor for the IEEE Transactions on Neural Systems and Rehabilitation Engineering, on the editorial boards of Brain Stimulation, Journal of Neural Engineering, Neuromodulation, and Medical and Biological Engineering and Computing, and as Sr. Technical Editor for Neurotech.



board of directors

GEOFFREY B. THROPE
GEOFFREY B. THROPE
Chairman

Mr. Thrope is the founder, president and CEO of NDI. He has more than 30 years of neurodevice experience conducting academic research and leading commercial product development, sales and marketing and business development in the neurodevice industry.  As a leading neurodevice entrepreneur, Mr. Thrope has achieved a successful track record of significant returns to his investors.  He founded NDI in 2002 to develop and commercialize neurodevice products, establishing three ventures and returning over 150 times the original investment back to shareholders in its first exit.  Prior to forming NDI, Mr. Thrope served as Vice President of New Business Development at NeuroControl Corporation, where he helped attract over $30 million in venture capital investment.  He is the inventor on over 60 neurostimulation patents issued and pending, and has published and presented more than 50 academic articles.  He earned a Bachelor of Science degree in Biomedical Engineering from Case Western Reserve University.



MARIA E. BENNETT
MARIA E. BENNETT
President, CEO and Founder

Maria (Walker) Bennett has led SPR Therapeutics since its inception. Prior to the formation of SPR, Ms. Bennett served as the VP of Clinical Affairs at NDI Medical, LLC a medical device development company where she played a vital role in the development of a neurostimulation system addressing urinary incontinence, which was acquired by Medtronic in 2008 company for $42 million. Prior to joining NDI, Ms. Bennett was a Clinical Project Manager at Boston Scientific, leading a team that conducted a large, multi-center clinical trial demonstrating safety and efficacy of an innovative angioplasty balloon, and achieving a 510(k) clearance for this product. Prior to this, she was the Manager of Clinical Studies and Director of Research and Development at NeuroControl Corp., where she co-developed a neurostimulation treatment for post-stroke shoulder pain. In 2009, she was selected by Springboard Enterprises as one of thirty female entrepreneurs from over 100 applicants to present at its LifeScience Venture Forums. She is the inventor of the SPRINT™ System, having patents issued and pending. Ms. Bennett holds a master’s degree in biomedical engineering from Case Western Reserve University and a bachelor’s degree from Miami University (OH) in engineering management.



LES C. VINNEY
LES C. VINNEY
Managing Director

Mr. Vinney is retired president, CEO and director of STERIS Corporation, a public company that develops, manufactures and markets a wide range of infection prevention and surgical support systems, products, services and technologies, where he served in these roles from 2000-2007.

Previously, he was senior vice president and CFO at Goodrich Corporation. Mr. Vinney is a board member of Campbell Soup Company, Patterson Companies, University Hospitals, and Cleveland HeartLab, and has served as chairman of NorTech (Northeast Ohio Technology Coalition) and a board member of the Federal Reserve Bank of Cleveland, and AdvaMed (Advanced Medical Device Association).